Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis: Experience from 92 Sites in an Open-Label US Expanded Access Program
Crossref DOI link: https://doi.org/10.1007/s41030-017-0049-z
Published Online: 2017-09-06
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lancaster, Lisa
Morrison, Lake
Auais, Alexander
Ding, Beiying
Iqbal, Ahmar
Polman, Boris
Flaherty, Kevin R.
Funding for this research was provided by:
F. Hoffmann-La Roche/Genentech, Inc.